VistaGen Therapeutics, Inc.VTGNNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-67.84M
↓ 95% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
$-34.80M
Historical baseline
PeriodValueYoY Change
TTM$-67.84M-22.6%
2025$-55.34M-70.5%
2024$-32.45M+44.7%
2023$-58.74M-24.8%
2022$-47.05M-169.8%
2021$-17.44M+15.6%
2020$-20.65M+15.6%
2019$-24.47M-71.6%
2018$-14.25M-45.9%
2017$-9.77M-